The cell surface glycosphingolipids SSEA-3 and SSEA-4 are not essential for human ESC pluripotency

Stem Cells

Volumn 25, Issue 1, 2007, Pages 54-62

  Brimble, Sandii N ^a   Sherrer, Eric S ^a   Uhl, Elizabeth W ^b   Wang, Elaine ^c   Kelly, Samuel ^c   Merrill Jr , Alfred H ^c   Robins, Allan J ^a   Schulz, Thomas C ^a  

^a Georgia Biobusiness Center   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

^c GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Cell surface markers; Differentiation; Embryoid body; Human embryonic stem cells; Oct 4 expression levels

Indexed keywords

GLYCOSPHINGOLIPID; SPHINGOLIPID; STAGE SPECIFIC EMBRYO ANTIGEN 3; STAGE SPECIFIC EMBRYO ANTIGEN 4;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL SURFACE; CONTROLLED STUDY; CYTOMETRY; EMBRYONIC STEM CELL; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LIPOGENESIS; PLURIPOTENT STEM CELL; TANDEM MASS SPECTROMETRY; TERATOMA;

ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CELLS, CULTURED; EMBRYONIC STEM CELLS; FLOW CYTOMETRY; GENE DELETION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GLYCOSPHINGOLIPIDS; HUMANS; PLURIPOTENT STEM CELLS;

EID: 33845966350     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2006-0232     Document Type: Article

References (51)

1. Thomson JA, Itskovitz-Eldor J, Shapiro SS et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145-1147.
2. Reubinoff BE, Pera MF, Fong CY et al. Embryonic stem cell lines from human blastocysts: Somatic differentiation in vitro. Nat Biotechnol 2000;18:399-404.
3. Liew CG, Moore H, Ruban L et al. Human embryonic stem cells: Possibilities for human cell transplantation. Ann Med 2005;37:521-532.
4. Hoffman LM, Carpenter MK. Characterization and culture of human embryonic stem cells. Nat Biotechnol 2005;23:699-708.
5. Nichols J, Zevnik B, Anastassiadis K et al. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 1998;95:379-391.
6. Matin MM, Walsh JR, Gokhale PJ et al. Specific knockdown of Oct4 and beta2-microglobulin expression by RNA interference in human embryonic stem cells and embryonic carcinoma cells. STEM CELLS 2004;22:659-668.
7. Boyer LA, Lee TI, Cole MF et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 2005;122:947-956.
8. Hyslop L, Stojkovic M, Armstrong L et al. Downregulation of NANOG induces differentiation of human embryonic stem cells to extraembryonic lineages. STEM CELLS 2005;23:1035-1043.
9. Abeyta MJ, Clark AT, Rodriguez RT et al. Unique gene expression signatures of independently-derived human embryonic stem cell lines. Hum Mol Genet 2004;13:601-608.
10. Bhattacharya B, Miura T, Brandenberger R et al. Gene expression in human embryonic stem cell lines: Unique molecular signature. Blood 2004;103:2956-2964.
11. Brandenberger R, Khrebtukova I, Thies RS et al. MPSS profiling of human embryonic stem cells. BMC Dev Biol 2004;4:10.
12. Richards M, Tan SP, Tan JH et al. The transcriptome profile of human embryonic stem cells as defined by SAGE. STEM CELLS 2004;22:51-64.
13. Zeng X, Miura T, Luo Y et al. Properties of pluripotent human embryonic stem cells BG01 and BG02. STEM CELLS 2004;22:292-312.
14. Sperger JM, Chen X, Draper JS et al. Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. Proc Natl Acad Sci U S A 2003;100:13350-13355.
15. Amit M, Carpenter MK, Inokuma MS et al. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev Biol 2000;227:271-278.
16. Pyle AD, Lock LF, Donovan PJ. Neurotrophins mediate human embryonic stem cell survival. Nat Biotechnol 2006;24:344-350.
17. Rosler ES, Fisk GJ, Ares X et al. Long-term culture of human embryonic stem cells in feeder-free conditions. Dev Dyn 2004;229:259-274.
18. Andrews PW, Damjanov I, Simon D et al. Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Differentiation in vivo and in vitro. Lab Invest 1984;50:147-162.
19. Andrews PW, Goodfellow PN, Shevinsky LH et al. Cell-surface antigens of a clonal human embryonal carcinoma cell line: Morphological and antigenic differentiation in culture. Int J Cancer 1982;29:523-531.
20. Henderson JK, Draper JS, Baillie HS et al. Preimplantation human embryos and embryonic stem cells show comparable expression of stage-specific embryonic antigens. STEM CELLS 2002;20:329-337.
21. Enver T, Soneji S, Joshi C et al. Cellular differentiation hierarchies in normal and culture-adapted human embryonic stem cells. Hum Mol Genet 2005;14:3129-3140.
22. Kannagi R, Cochran NA, Ishigami F et al. Stage-specific embryonic antigens (SSEA-3 and -4) are epitopes of a unique globo-series ganglioside isolated from human teratocarcinoma cells. Embo J 1983;2:2355-2361.
23. Futerman AH, Hannun YA. The complex life of simple sphingolipids. EMBO Rep 2004;5:777-782.
24. Merrill AH Jr. De novo sphingolipid biosynthesis: A necessary, but dangerous, pathway. J Biol Chem 2002;277:25843-25846.
25. Shayman JA. Sphingolipids. Kidney Int 2000;58:11-26.
26. Solter D, Knowles BB. Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). Proc Natl Acad Sci U S A 1978;75:5565-5569.
27. Yamashita T, Wada R, Sasaki T et al. A vital role for glycosphingolipid synthesis during development and differentiation. Proc Natl Acad Sci U S A 1999;96:9142-9147.
28. Uemura K, Sugiyama E, Tamai C et al. Effect of an inhibitor of glucosylceramide synthesis on cultured rabbit skin fibroblasts. J Biochem (Tokyo) 1990;108:525-530.
29. Fenderson BA, Radin N, Andrews PW. Differentiation antigens of human germ cell tumours: Distribution of carbohydrate epitopes on glycolipids and glycoproteins analyzed using PDMP, an inhibitor of glycolipid synthesis. Eur Urol 1993;23:30-36; discussion 36-37.
30. Andrews PW, Damjanov I, Simon D et al. A pluripotent human stem-cell clone isolated from the TERA-2 teratocarcinoma line lacks antigens SSEA-3 and SSEA-4 in vitro, but expresses these antigens when grown as a xenograft tumor. Differentiation 1985;29:127-135.
31. Tippett P, Andrews PW, Knowles BB et al. Red cell antigens P (globoside) and Luke: Identification by monoclonal antibodies defining the murine stage-specific embryonic antigens -3 and -4 (SSEA-3 and SSEA-4). Vox Sang 1986;51:53-56.
32. Cantin G, Lyonnais J. Anti-PP1Pk and early abortion. Transfusion 1983;23:350-351.
33. Fenderson BA, Andrews PW, Nudelman E et al. Glycolipid core structure switching from globo- to lacto- and ganglio-series during retinoic acid-induced differentiation of TERA-2-derived human embryonal carcinoma cells. Dev Biol 1987;122:21-34.
34. Miyake Y, Kozutsumi Y, Nakamura S et al. Serine palmitoyltransferase is the primary target of a sphingosine-like immunosuppressant, ISP-1/myriocin. Biochem Biophys Res Commun 1995;211:396-403.
35. Brimble SN, Zeng X, Weiler DA et al. Karyotypic stability, genotyping, differentiation, feeder free maintenance and gene expression sampling in three human embryonic stem cell lines derived prior to August 9, 2001. Stem Cells Dev 2004;13:585-597.
36. Mitalipova MM, Calhoun JD, Shin S et al. Human embryonic stem cell lines derived from discarded embryos. STEM CELLS 2003;21:521-526.
37. Plaia TW, Josephson R, Liu Y et al. Characterization of a new NIH registered variant human embryonic stem cell line BG01V: A tool for human embryonic stem cell research. STEM CELLS 2005;24:531-546.
38. Zeng X, Chen J, Liu Y et al. BG01V: A variant human embryonic stem cell line which exhibits rapid growth after passaging and reliable dopaminergic differentiation. Restor Neurol Neurosci 2004;22:421-428.
39. Xu C, Inokuma MS, Denham J et al. Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechnol 2001;19:971-974.
40. Schulz TC, Noggle SA, Palmarini GM et al. Differentiation of human embryonic stem cells to dopaminergic neurons in serum-free suspension culture. STEM CELLS 2004;22:1218-1238.
41. Merrill AH Jr., Sullards MC, Allegood JC et al. Sphingolipidomics: High-throughput, structure-specific, and quantitative analysis of sphingolipids by liquid chromatography tandem mass spectrometry. Methods 2005;36:207-224.
42. Liu Y, Shin S, Zeng X et al. Genome wide profiling of human embryonic stem cells (hESCs), their derivatives and embryonal carcinoma cells to develop base profiles of U.S. Federal government approved hESC lines. BMC Dev Biol 2006;6:20.
43. Bibikova M, Chudin E, Wu B et al. Human embryonic stem cells have a unique epigenetic signature. Genome Res 2006;16:1075-1083.
44. Shayman JA, Abe A, Hiraoka M. A turn in the road: How studies on the pharmacology of glucosylceramide synthase inhibitors led to the identification of a lysosomal phospholipase A2 with ceramide transacylase activity. Glycoconj J 2004;20:25-32.
45. Draper JS, Pigott C, Thomson JA et al. Surface antigens of human embryonic stem cells: Changes upon differentiation in culture. J Anat 2002;200(Pt 3):249-258.
46. Ozawa M, Muramatsu T, Solter D. SSEA-1, a stage-specific embryonic antigen of the mouse, is carried by the glycoprotein-bound large carbohydrate in embryonal carcinoma cells. Cell Differ 1985;16:169-173.
47. Shevinsky LH, Knowles BB, Damjanov I et al. Monoclonal antibody to murine embryos defines a stage-specific embryonic antigen expressed on mouse embryos and human teratocarcinoma cells. Cell 1982;30:697-705.
48. Katagiri YU, Kiyokawa N, Nakamura K et al. Laminin binding protein, 34/67 laminin receptor, carries stage-specific embryonic antigen-4 epitope defined by monoclonal antibody Raft. 2. Biochem Biophys Res Commun 2005;332:1004-1011.
49. Bieberich E, Silva J, Wang G et al. Selective apoptosis of pluripotent mouse and human stem cells by novel ceramide analogues prevents teratoma formation and enriches for neural precursors in ES cell-derived neural transplants. J Cell Biol 2004;167:723-734.
50. Pebay A, Wong RC, Pitson SM et al. Essential roles of sphingosine-1-phosphate and platelet-derived growth factor in the maintenance of human embryonic stem cells. STEM CELLS 2005;23:1541-1548.
51. Fahy E, Subramaniam S, Brown HA et al. A comprehensive classification system for lipids. J Lipid Res 2005;46:839-861.